These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 37244870)
1. Things We Do for No Reason™: Withholding pharmacologic venous thromboembolism prophylaxis in hospitalized patients with inflammatory bowel disease. Lee HD J Hosp Med; 2023 Nov; 18(11):1038-1040. PubMed ID: 37244870 [No Abstract] [Full Text] [Related]
2. The Risk of Blood Transfusion With the Use of Pharmacologic Venous Thromboembolism Prophylaxis During Hospitalization for Inflammatory Bowel Disease Exacerbation: A Time to Event Analysis. Khuwaja S; Kohn N; Sanghani SS; Khan S; Swaminath A; Sultan K Am J Ther; 2023 May; 30(3):e288-e291. PubMed ID: 37278710 [No Abstract] [Full Text] [Related]
3. Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease. Allen JI Dig Dis Sci; 2013 Jan; 58(1):1-4. PubMed ID: 23179161 [No Abstract] [Full Text] [Related]
4. An Electronic Alert System Is Associated With a Significant Increase in Pharmacologic Venous Thromboembolism Prophylaxis Rates Among Hospitalized Inflammatory Bowel Disease Patients. Mathers B; Williams E; Bedi G; Messaris E; Tinsley A J Healthc Qual; 2017; 39(5):307-314. PubMed ID: 27153049 [TBL] [Abstract][Full Text] [Related]
5. Prevention of venous thromboembolism in hospitalized patients with inflammatory bowel disease. Chande N Inflamm Bowel Dis; 2013 Mar; 19(3):669-71. PubMed ID: 23385239 [TBL] [Abstract][Full Text] [Related]
6. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. Tinsley A; Naymagon S; Trindade AJ; Sachar DB; Sands BE; Ullman TA J Clin Gastroenterol; 2013 Jan; 47(1):e1-6. PubMed ID: 22476043 [TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of venous thromboembolism in IBD. Nguyen GC; Yeo EL Lancet; 2010 Feb; 375(9715):616-7. PubMed ID: 20149426 [No Abstract] [Full Text] [Related]
8. [Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"]. Dávid M; Losonczy H; Udvardy M; Boda Z; Blaskó G; Tar A; Pfliegler G Orv Hetil; 2010 Aug; 151(34):1365-74. PubMed ID: 20705551 [TBL] [Abstract][Full Text] [Related]
9. Things We Do for No Reason™: Universal Venous Thromboembolism Chemoprophylaxis in Low-Risk Hospitalized Medical Patients. Barlow B; Barlow A; Breu AC J Hosp Med; 2021 May; 16(5):301-303. PubMed ID: 33357322 [No Abstract] [Full Text] [Related]
10. Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease. Faye AS; Hung KW; Cheng K; Blackett JW; Mckenney AS; Pont AR; Li J; Lawlor G; Lebwohl B; Freedberg DE Inflamm Bowel Dis; 2020 Aug; 26(9):1394-1400. PubMed ID: 31689354 [TBL] [Abstract][Full Text] [Related]
11. Current Venous Thromboembolism Chemoprophylaxis Practices After Surgery for Inflammatory Bowel Diseases. Bickston SJ; Patrone MV Inflamm Bowel Dis; 2022 Aug; 28(8):1296-1297. PubMed ID: 35452122 [TBL] [Abstract][Full Text] [Related]
12. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease. Sam JJ; Bernstein CN; Razik R; Thanabalan R; Nguyen GC Dig Dis Sci; 2013 Jan; 58(1):46-52. PubMed ID: 23053902 [TBL] [Abstract][Full Text] [Related]
13. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients. Ra G; Thanabalan R; Ratneswaran S; Nguyen GC J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817 [TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study. Heo CM; Kim TJ; Kim ER; Hong SN; Chang DK; Yang M; Kim S; Kim YH Sci Rep; 2021 Jan; 11(1):2025. PubMed ID: 33479464 [TBL] [Abstract][Full Text] [Related]
15. [Prevention and treatment of thromboembolism in patients with inflammatory bowel disease]. Park JJ Korean J Gastroenterol; 2015 Mar; 65(3):151-8. PubMed ID: 25797378 [TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting. Murthy SK; Robertson McCurdy AB; Carrier M; McCurdy JD Thromb Res; 2020 Oct; 194():26-32. PubMed ID: 32563061 [TBL] [Abstract][Full Text] [Related]
17. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center. Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933 [TBL] [Abstract][Full Text] [Related]
18. IBD: which patients with IBD are at risk of venous thromboembolism? Koutroubakis IE Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):307-8. PubMed ID: 20523349 [No Abstract] [Full Text] [Related]
19. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease. Dwyer JP; Javed A; Hair CS; Moore GT Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease. Lee KE; Lim F; Colombel JF; Hur C; Faye AS Inflamm Bowel Dis; 2022 Aug; 28(8):1169-1176. PubMed ID: 34591970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]